Product Details

Butagran Equi 200 mg/g Oral Powder for Horses

• MA holder: Dopharma Research B.V.
• VM number: 28365/4004
• Territory: Great Britain
• Aligned product: View aligned product details
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
  • View Post Authorisation Assessment
• Date of issue: 08/02/2013
• Authorisation route: National
• Active substances:
  • Phenylbutazone
• Controlled drug: No
• Target species:
  • Horses
• Distribution category: POM-V
• Distributors:
  • Bimeda (Division of Cross Vetpharm Group (UK) Ltd)